首页> 外文OA文献 >Spiral Tissue Microarrays as Next Evolutionary Step in the High-density Tissue Microarray Technology
【2h】

Spiral Tissue Microarrays as Next Evolutionary Step in the High-density Tissue Microarray Technology

机译:螺旋组织微阵列是高密度组织微阵列技术的下一步发展

摘要

Tissue microarray (TMA) is a well-established technique that connects basic research with clinical applications that allow the validation of many pathobiologic events from gene expression dysregulation to genomic aberrations. However, conventional TMAs have several limitations such as limited representation of tissue heterogeneity, destruction of donor tissue blocks due to coring and usage of particular specimens that have limited evaluable material (tissue from thin specimens or needle biopsies). We have developed a novel method, which we termed "Spiral TMA" that generates TMAs that allow for improved representation of the donor tissue while keeping the architectural details of the donor block intact. This technology is ideal for specimens with limited tissue without the need to punch holes into the original block and therefore preserving the tissue integrity. In this report, we describe the methodology of constructing Spiral TMA and demonstrate the validation of tumor representation and tissue heterogeneity by comparing Spiral TMA to conventional TMA using immunohistochemical staining to EGFR and CK7.
机译:组织微阵列(TMA)是一项成熟的技术,将基础研究与临床应用相结合,可以验证从基因表达失调到基因组畸变的许多病理生物学事件。然而,常规的TMA具有一些局限性,例如组织异质性的有限表示,由于取芯而导致的供体组织块的破坏以及具有可评估材料有限的特定标本的使用(薄标本或针头活检组织)。我们已经开发了一种新颖的方法,称为“螺旋TMA”,它可以生成TMA,从而在保持供体块的结构细节不变的情况下改善供体组织的表示。这项技术非常适合组织有限的标本,而无需在原始块上打孔,从而保持组织完整性。在此报告中,我们描述了构建螺旋TMA的方法,并通过使用针对EGFR和CK7的免疫组织化学染色将螺旋TMA与常规TMA进行比较,证明了肿瘤表征和组织异质性的验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号